Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Edge Therapeutics Inc.
DescriptionMicroparticle formulation of aprotinin, a pancreatic trypsin inhibitor
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentDiscovery
Standard Indication Neurology (unspecified)
Indication DetailsTreat chronic subdural hematoma
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today